Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials
Journal Article
·
· International Journal of Radiation Oncology, Biology and Physics
- RTOG Headquarters, Philadelphia, PA (United States)
- Wayne State Univ., Detroit, MI (United States)
- State Univ., Brooklyn, NY (United States); and others
Promising results from new approaches such as radiosurgery or stereotactic radiosurgery of brain metastases have recently been reported. Are these results due to the therapy alone or can the results be attributed in part to patient selection? An analysis of tumor/patient characteristics and treatment variables in previous RTOG brain metastases studies was considered necessary to fully evaluate the benefit of these new interventions.
- OSTI ID:
- 471549
- Report Number(s):
- CONF-9510337-; ISSN 0360-3016; TRN: 96:005695-0011
- Journal Information:
- International Journal of Radiation Oncology, Biology and Physics, Vol. 32, Issue Suppl.1; Conference: 37. therapeutic radiology and oncology annual meeting, Miami Beaach, FL (United States), 8-11 Oct 1995; Other Information: PBD: 1995
- Country of Publication:
- United States
- Language:
- English
Similar Records
Secondary Analysis of RTOG 9508, a Phase 3 Randomized Trial of Whole-Brain Radiation Therapy Versus WBRT Plus Stereotactic Radiosurgery in Patients With 1-3 Brain Metastases; Poststratified by the Graded Prognostic Assessment (GPA)
A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320
Brain Metastases From Breast Carcinoma: Validation of the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification and Proposition of a New Prognostic Score
Journal Article
·
Sat Nov 01 00:00:00 EDT 2014
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:471549
+6 more
A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320
Journal Article
·
Mon Apr 01 00:00:00 EDT 2013
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:471549
+11 more
Brain Metastases From Breast Carcinoma: Validation of the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification and Proposition of a New Prognostic Score
Journal Article
·
Thu Nov 01 00:00:00 EDT 2007
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:471549
+9 more